Serum lipoproteins were measured during a single infusion of Intralipid and during parenteral nutrition with Intralipid and glucose. Postheparin plasma lipolytic enzymes and plasma LCAT activity were assayed before and after the parenteral nutrition. Both single and repeated infusions of Intralipid were followed by a significant rise of HDL 2 concentration (p < 0.01), whereas the HDL 3 decreased. The composition of HDL subclasses altered. The HDL 2 triglyceride and phospholipids increased, while the HDL 3 esterified cholesterol and protein decreased. In vitro incubation of serum with Intralipid alone caused no changes in the zonal profile of HDL subclasses, but hydrolysis of Intralipid by lipoprotein lipase was followed by conversion of HDL 3 into lighter particles floating in the density range of HDL 2 . The present results provide additional evidence for a precursor-product relationship between the HDL 2 and HDL 3 . During 4 days of parenteral nutrition with Intralipid, the basal (morning) values of serum total and VLDL triglyceride did not change. The LDL phospholipids increased progressively (from 67 to 98 mg/dl, p < 0.05). The total HDL cholesterol decreased and this change was due to the fall of HDL 3 cholesterol esters (from 19 to 12 mg/dl, p < 0.05). Also the basal values of apo A-l and A-ll in HDL 3 decreased. The basal level of the HDL 2 remained constant. Postheparin plasma LPL activity increased by 52% (p < 0.01) but hepatic lipase activity fell by 49% (p < 0.05). These changes may account for the maintenance of plasma HDL 2 , whereas the progressive fall of the basal HDL 3 is probably due to the lack of intestinal apoprotein synthesis during absent intestinal absorption. (Arteriosclerosis 3:607-615, November/December 1983)
HDL 3 density range to that of HDL 2 . This is consistent with the finding that in normal subjects the concentrations of HDL 2 and HDL 3 are inversely correlated. 2 The HDL, protein and phospholipids increase after the intake of a fatty meal. 7 " 8 The HDL concentration is positively related to the amount of dietary fat. A low fat-high carbohydrate diet results in a fall of plasma HDL concentration, 9 " 11 while a diet high in fat increases the HDL cholesterol. 12 In addition, the quality of ingested fat influences the plasma HDL levels. 13 " 17 Intralipid is a phoepholipid-stabilized fat emulsion widely used for parenteral nutrition and metabolized in a similar way as the chylomicrons. 18 In this study we have followed serum lipids and lipoproteins during single or repeated infusions of Intralipid in healthy volunteers and in patients receiving parenteral nutrition. In addition, the activities of postheparin plasma lipases and plasma LCAT activity were measured.
Methods
The experimental design included a single infusion of Intralipid in normal subjects and repeated daily infusions of Intralipid as a part of parenteral nutrition in postoperative patients. The experimental design and possible adverse effects were explained to each subject and formal consent was obtained.
Single Infusion of Intralipid
Eight healthy volunteers (six women and two men) between 21 and 41 years of age who were between 87% and 124% of ideal body weight 19 participated in the study. After a 10-hour overnight fast, the subjects received an intravenous bolus of 50 ml of 20% Intralipid (Vitrum, Sweden) followed by a 3-hour infusion of Intralipid at a rate of 50 ml per hour (total dose 200 ml, 40 g of fat).
Parenteral Nutrition with Intralipid
Six postoperative patients (two women, four men) were followed during total parenteral nutrition. Two patients were operated on for gastric cancer and four, for peptic ulcer. Their ages were between 33 and 66 years and their relative body weights ranged from 86% to 112%. All subjects were normolipidemic and nondiabetic. On the day of operation the patients received physiological saline. During the next 4 days only parenteral nutrition was given. The daily energy supply averaged 43 ± 4 kcal per kilogram of body weight, of which Intralipid provided 50%, 37% was supplied as glucose (given as 30% solution), and the rest was an amino acid mixture (Levamin 70, Leiras, Turku, Finland). The Intralipid (20% vol/vol) was infused over a 10-hour period (from 8 AM to 6 PM) and glucose and amino acids were given continuously for 24 hours. Electrolytes were administered according to individual needs. Trace elements (Tracefucin, 20 ml/day, Leiras, Turku, Finland) and vitamins (Soluvit, 1 ml/day, Vitrum, Sweden) were given daily.
Blood Sampling
In the single infusion experiment, serum lipoproteins were analyzed before and at 1, 3, and 5 hours after the start of the Intralipid infusion. During the parenteral nutrition programs the lipoprotein pattern was monitored at 8 AM and 2 PM on the first and fourth postoperative days and at 8 AM on the fifth day. Samples were taken in cooled tubes and 5.5 dithiobis (2-nitrobenzoicacid) (Sigma Chemical Company, St. Louis, Missouri) was added at a final concentration of 1.4 mmol/liter to fresh serum samples to inhibit LCAT activity and possible in vitro interconversion of HDL subclasses. 20
Heparin Test for the Assay of Lipase Activities
The postheparin plasma was obtained before the operations and on the fifth postoperative day after a 10-hour overnight fast. A bolus injection of heparin (Vitrum, Sweden, 100 IU per kg body weight) was given intravenously and blood was collected 15 minutes later into chilled heparinized tubes. Plasma was separated and stored frozen at -20°C. Assays of lipoprotein lipase and hepatic lipase activities were carried out using a specific immunochemical method. 21 The samples of each subject were assayed simultaneously. The enzyme activity was expressed as the /^mol of FFA released from the triolein substrate by 1 ml of plasma in 1 hour.
In Vitro Incubation of Intralipid with Lipoprotein Lipase
The effects of the hydrolysis of Intralipid by lipoprotein lipase on the distribution of HDL subfractions was also studied in vitro. One ml of human serum containing 36 mg/100 ml cholesterol in HDL (HDL, cholesterol, 7 mg/100 ml; HDL, phospholipid, 7.9 mg/100 ml; HDL, cholesterol, 29 mg/ml; HDL, phospholipid, 52 mg/100 ml, respectively) was incubated with 0 ix\ to 60 MI of 20% Intralipid in both the presence and the absence of LPL (13 /u.g, specific activity 29 mmol FFA/h/mg) purified from bovine milk by heparin-Sepharose. 22 We added 2 ml of 20% bovine serum albumin (Armour Pharmaceutical Company, Eastbourne, England) in 0.1 M Tris-HCI buffer (pH 8.6) to provide sufficient binding sites for free fatty acids released during lipolysis. The incubation was continued for 2 hours at 37°C. Thereafter, the density of the incubation mixture was adjusted to 1.40 g/ml with solid sodium bromide. The HDL subfraction distribution was analyzed from aliquots (2 ml) of incubation mixture using zonal ultracentrifugation in discontinuous gradient and a Beckman SW 40 rotor operated at 40,000 rpm for 21 hours at 15°C in a Beckman L-7-55 ultracentrifuge. 23 The gradients were discharged through a Uvicord III ultraviolet spectrophotometer (LKB, Bromma, Sweden) for the measurements of absorbance at 280 nm.
Separation of Llpoprotelns
The lipoproteins were separated by sequential flotation 24 in a Beckman L 70 ultracentrifuge (Beckman Instrument Incorporated, Palo Alto, California) using a Type 50.3 Ti Beckman rotor. Chylomicrons and Intralipid were isolated from fresh serum by spinning for 30 minutes at 18,000 rpm. Chylomicron-free serum was overlaid with 0.16 M NaCI with 1 mM EDTA (d = 1.006 g/ml). VLDL was floated by spinning for 18 hours at 38,000 rpm and was then removed. The density of the bottom fraction was raised to 1.063 with a mixture of KBr (353 g/l) and NaCI (153 g/l). The LDL in the top layer was removed after centrifugation for 24 hours at 38,000 rpm. The density of the infranatant was adjusted to 1.125 g/ml with the KBr and NaCI mixture and the HDL, (d = 1.063-1.125 g/ ml) was separated by spinning for 48 hours at 38,000 rpm. The top layer (HDL,) was removed and the density of the bottom was raised to 1.210 g/ml with the salt mixture. The HDL, was isolated by ultracentrifugation for 65 hours at 38,000 rpm and removed.
All lipoprotein fractions were dialyzed overnight against 0.15 M NaCI with 0.05% EDTA (pH 7.4). The recovery of cholesterol, triglyceride, and phospholipids in the isolated lipoprotein fractions averaged 92% ± 2%, 97% ± 2%, and 82% ± 3%, respectively.
Analytical Methods
The concentration of total cholesterol was measured by the enzymatic colorimetric method using lipase that was free of phospholipase activity (Kit 187313, Boehringer Diagnostica Mannheim GmbH). Triglyceride 25 was determined using Kit 297771, Boehringer Mannheim GmbH, and phospholipids 26 were measured from the whole serum and lipoprotein fractions. Free cholesterol was analyzed from LDL and HDL subfractions by Kit 310328 from Boehringer Mannheim GmbH. The HDL subfractions were also analyzed for total protein 27 and apo A-l and A-ll. 28 The sum of cholesterol, triglyceride, phospholipid, and protein concentrations in HDL, and HDLj was taken to be equivalent to the concentration of HDL, and HDLj. Lecithin cholesteryl acyltransferase (LCAT) activity was measured using the method of Stokke and Norum. 29 The enzyme activity is expressed as the /Limoles of cholesterol esters formed per litre of plasma per hour.
Statistical Analyses
Statistical analyses were carried out by using the standard programs for nonpaired and paired /-tests in a Honeywell Bull 66/20 computer and the nonparametric test for paired differences (Wilcoxon).
Results

Serum Llpids and Upoprotelns During a Single 3-hour Infusion of Intralipid
The Intralipid infusion was followed by an increase in triglyceride, phospholipids, and cholesterol in VLDL (Table 1 ). In addition, there were infused triglyceride and phospholipids in the chylomicron fraction. The LDL and HDL cholesterol decreased during the infusion. These acute changes had disappeared by 2 hours after the end of the infusion. Serum and LDL phospholipids continued to rise after the end of the infusion.
The concentration of subfractions within the HDL density range showed reciprocal changes. The HDL, increased by 11% (p < 0.01) and the HDL, decreased by 27% (p < 0.01) ( Figure 1 ). The rise of HDL, was due to an increase in its triglyceride and phospholipids, whereas the fall of HDLj was mainly caused by the reduction of its cholesterol and protein concentration ( Figure 1 ). The HDLj apo A-l fell from 55 ± 3 mg/dl to 41 ± 2 mg/dl (p < 0.01); apo A-ll fell from 22 ± 2 to 16 ± 2 mg/dl (p < 0.01). The apo A-l and A-ll of HDL^ did not change. The observed changes altered the composition of HDL subfractions. Both HDL, and HDL, particles became relatively enriched in triglyceride and phospholipids but were depleted of cholesterol and proteins ( Table 2) .
Serum Llplds and Lipoproteins During Parenteral Nutrition with Intralipid
The basal (morning) levels of serum total triglyceride, cholesterol, and phospholipids did not change during the parenteral nutrition when the fat infusion was discontinued 12 hours earlier (Table 3 ). There were, however, significant alterations of lipoproteins.
The HDL cholesterol showed a tendency to decrease but the LDL phospholipids increased progressively ( Table 3 ). The basal values of the HDL, components remained unchanged, but the HDL, decreased significantly, mainly because of a fall of esterified cholesterol (EC) and phospholipids ( Table 4 ).
The rise of chylomicron and VLDL triglyceride concentrations during Intralipid infusion was more pronounced on the first than on the fourth day (Table 3) . Serum total cholesterol and LDL and HDL cholesterol fell only after the first infusion of Intralipid. The reduction of LDL cholesterol was caused mainly by the reduction of cholesterol esters (94 ± 10 vs 75 ± 8 mg/dl, p < 0.05). The triglyceride/cholesterol ester ratio in LDL increased from 0.33 to 0.55 (p < 0.05). LDL and HDL phospholipids increased after the infusions but the changes were significant only on the fourth day (Table 3) .
Marked changes occurred in HDL subtractions. The HDL, mass concentration increased by an average of 44% (p < 0.01) after the first infusion and by 26% (p < 0.05) after the fourth infusion, whereas the HDL3 decreased by 26% (p < 0.05) and by 17% (NS), respectively. The HDL, triglyceride, phospholipid, and protein rose, while the HDLj cholesterol (free and esterified) remained constant ( Table 4 ). The reduction of HDL3 cholesterol and proteins was responsible for the fall of the HDL3 mass (Table 4 ).
Both free and esterified cholesterol in HDL3 fell, but quantitatively the reduction of cholesterol esters was more marked. Apo A-l and A-ll in the HDL subtractions changed reciprocally: HDL, A-l and A-ll increased, but those of HDL, decreased ( Table 5 ). The observed changes caused marked compositional alterations in HDL subfractions. Both HDL subtractions became relatively enriched in triglyceride and phospholipids but depleted in cholesterol esters and proteins ( Table 6 ).
Postheparln Plasma Llpase and Plasma LCAT Activities During Parenteral Nutrition
The parenteral nutrition resulted in an increase of postheparin plasma LPL activity in each subject. The 
Table 5. Concentration (mg/dl) of Apo A-l and A-ll In HDL Subfractions before and during Parenteral Nutrition with Intralipid
In Vitro Incubation of Intralipid with Lipoprotein Lipase
To separate a redistribution of components between Intralipid and HDL subtractions from those caused by lipolysis, serum and Intralipid were incubated in vitro with and without added lipoprotein li-pase. Figure 2 A shows the zonal HDL profile in a patient who had primarily low HDL, concentration in serum. This serum was deliberately selected to demonstrate the interconversion of HDL, into HDL,. Figure 2 F shows that the incubation of serum with Intralipid alone caused no detectable changes in the zonal profile of HDL subfractions. The amount of Intralipid (60 /ul/ml equivalent to 0.7 mg/ml) in the incubation mixture roughly corresponded to the estimated concentration of Intralipid in plasma during parenterai nutrition presuming that the plasma volume was 2500-3000 ml. The addition of LPL into serum without Intralipid was followed by detectable changes in the HDL profile with the appearance of particles floating in the range of HDL, ( Figure 2B ). The accumulation of these lighter particles became even more evident upon the addition of increasing amounts of Intralipid (Figure 2 C, E) . Ultimately, almost all the HDL3 was converted into particles floating in the HDL, density range (Figure 2 E ).
Discussion
The present data provide additional support to the view that HDL, is generated during the catabolism of triglyceride-rich particles by lipoprotein lipase. 1B oth single and repeated daily infusions of Intralipid were followed by a rise in the concentration of HDL,, while the HDLj decreased. In vitro LPL-induced hydrolysis of Intralipid was followed by a conversion of HDLj into lighter particles floating in the density range of HDLj. These reciprocal changes of the HDL subclasses provide further evidence for a precursorproduct relationship between HDL 2 and HDL,. 2 
' 3
A relevant question is how closely the metabolism of Intralipid corresponds to that of natural chylomicrons and VLDL. The elimination of Intralipid-triglyceride from circulation is kinetically similar to that of chylomicrons. 18 Also the in vitro enzyme kinetics of the hydrolysis of Intralipid and chylomicrons by lipoprotein lipase resemble each other. 30 A basic difference between Intralipid and chylomicrons is that Intralipid contains no cholesterol or apoproteins. However, in vivo and in vitro data have shown that Intralipid particles can pick up and bind apoproteins from plasma lipoproteins, 31 " 34 the apoprotein pattern being close to that of chylomicrons. 31 In addition, Intralipid exposed to plasma combines with polar lipids like free cholesterol with a concomitant loss of phospholipids. 31 -34 These reactions are so rapid that the transfer of apoproteins in vivo occurs in minutes. 32 The present in vitro studies clearly demonstrated that a transfer of apoproteins and/or other constituents from plasma lipoproteins to Intralipid did not involve any change in the subfraction distribution of HDL. On the other hand, lipolysis of Intralipid by LPL was followed by a definite disappearance of HDLj with a simultaneous increase of lighter particles floating in the density range of HDLj. Therefore, we conclude that the changes observed in HDL subfractions during Intralipid infusions reflect active metabolic transformation rather than a mere exchange of lipid and protein constituents between lipoprotein particles.
The composition of HDL subfractions showed similar changes after infusions of Intralipid. Both HDL^ and HDLj particles were enriched in triglycerides and phospholipids. HDLj particles were simultaneously depleted of esterified cholesterol and proteins. This change indicates that within both HDLj and HDLj density range, a shift occurred toward lighter and larger particles. 3536 Weinberg and Scanu 34 have shown that during in vitro incubation of Intralipid with HDL and exchange proteins, the hy-drated density of both HDLj and HDL, particles is decreased and the particle diameter is increased. A similar density shift is also seen after an oral fat load. 37 Because Intralipid contains no cholesterol, the increment of cholesterol in chylomicrons and VLDL during Intralipid infusion must be derived from other lipoproteins and/or from cell membranes. We measured both free and esterified cholesterol of VLDL during parenteral nutrition. These partially incomplete data suggest that the observed change was mainly caused by the accumulation of esterified cholesterol. It is well documented that plasma exchange proteins transfer esterified cholesterol from HDL to VLDL while VLDL triglyceride is transported to the reverse direction. 38 " 40 The observed fall of esterified cholesterol in HDL3 during Intralipid infusion suggests that the HDLj is the donor of cholesterol esters in the exchange process. Our current data agree with previous observations. First, the incubation of Intralipid with HDL in vitro is followed by a reciprocal exchange of cholesteryl esters and triglyceride. 34 Second, an oral administration of fat is associated with a fall of esterified cholesterol in HDL3. 37 The observed fall of esterified cholesterol in LDL is consistent with the in vitro data by Deckelbaum et al. 41 who showed that VLDL is also an acceptor for cholesterol esters from LDL. This process is dependent on transfer protein and may provide a pathway to get rid of excess cholesterol ester accumulation in LDL during catabolism of VLDL. 41 The rise of HDL 2 phospholipids during Intralipid infusion is consistent with previous data. Mass transfer of phospholipids from chylomicrons to HDL, particularly to HDL 2 , occurs in vitro 34 and in vivo after oral fat intake. 7 -83742 In the rat, phospholipids from injected chylomicrons are recovered in HDL. 4344 Intralipid infusions caused reciprocal changes of both apo A-l and A-ll between HDL subclasses. The fall of HDLj apo A-l and A-ll could reflect the transfer of these apoproteins to Intralipid. 3134 It is possible that during lipolysis, redistribution of apo A-l and A-ll occurs and causes their accumulation into HDLj. Oral administration of fat is followed by a transfer of apo A from chylomicrons to HDL,. 37 ' 42 Transfer of apo A proteins from infused chylomicrons to HDLj has also been demonstrated in animal experiments. 4344 It is evident that both the composition and concentration of HDL subfractions vary during the day according to the patient's nutritional state and are different in the fasting state and in the postprandial phase.
Repeated daily infusions of 130 g of Intralipid did not increase serum basal triglyceride concentration. 45 Furthermore, the levels of serum chylomicrons and VLDL triglyceride during infusions of Intralipid rose less on the fourth day than after the first infusion, suggesting that the catabolism of Intralipid was adaptively improved. This is supported by the significant increase of postheparin plasma lipoprotein lipase activity during the parenteral nutrition period. Our previous data agrees that a similar parenter-al nutrition program increases adipose tissue lipoprotein lipase activity. 45 Also consistent with our earlier results is the finding that the total HDL cholesterol level decreased during the parenteral nutrition period. 45 This change was due to a progressive fall of HDLj cholesterol, particularly that of esterified cholesterol. Concomitantly, the concentrations of apo A-l and A-ll in HDL, fell. A natural explanation for these changes would be a decrease of intestinal apoprotein synthesis during absent intestinal absorption. Secondarily, this would cause insufficient LCAT activation and inappropriate esterification of cholesterol.
The maintenance of the HDL, level during parenteral nutrition can be due either to the enhanced formation or to the decreased catabolism of HDL,. It may be significant in this context that postheparin plasma hepatic lipase activity fell by 50% during parenteral nutrition. This enzyme is involved in the degradation of HDL, particles; 46 ""* 8 a low hepatic lipase activity retards the catabolism of HDL, with a subsequent increase in the plasma level. The combination of high lipoprotein lipase activity with a low hepatic lipase activity particularly favors the rise of HDL, and the fall of HDLj.
Parenteral nutrition with Intralipid was associated with a rise of LDL phospholipids. This agrees with previous data. 49 -M After Intralipid infusion, the density range of LDL contains abnormal LDL which resembles Lp X. 5051 This is thought to be due to the slow clearance rate of Lp X from circulation. 505 ' The infusion rates of Intralipid in parenteral nutrition apparently exceed the VLDL or LDL phospholipid removal capacity and this is followed by an accumulation of phospholipids into serum and LDL. In normal subjects the input of phospholipids from Intralipid averaged 2.4 g; at 2 hours after the end of the Intralipid, roughly 45% of the infused phospholipids were still present in lipoproteins. This figure is consistent with those given by Untracht. 51 
